01
Five start-up risks that can delay site activation
A practical checklist covering document quality, contracting dependencies, training, systems, and site readiness.
Clinical operations perspective
Operational priorities for emerging sponsors.
A focused view of the decisions that influence outsourcing, study start-up, site delivery, governance, and inspection readiness.
Discuss your needs02
How an emerging biotech can evaluate a right-sized CRO
A diligence framework focused on leadership, the proposed team, delivery assumptions, governance, and quality foundations.
03
Full-service, FSP, or hybrid: choosing the right model
Questions sponsors can use to determine the right balance of ownership, flexibility, and internal oversight.
04
Site feasibility beyond enrollment projections
Why operational burden, competing trials, staffing, systems, and assessment workflows belong in feasibility decisions.
05
Turn status reporting into sponsor decisions
How concise governance can connect risks, owners, due dates, forecast impact, and decision pathways.
06
Inspection readiness begins at study start
Practical habits that support timely filing, clear ownership, reconciliation, and evidence of oversight.
Sponsor resource
Download the Aarvap capabilities brochure.
Discuss your program
Define the right first engagement.
Share your program stage, critical milestones, countries, sites, and the functions requiring ownership or support.